Center for Scientific Review; Notice of Closed Meetings, 29757-29758 [2013-12016]

Download as PDF Federal Register / Vol. 78, No. 98 / Tuesday, May 21, 2013 / Notices may limit the number of participants from each organization based on space limitations. Registrants will receive confirmation once they have been accepted. Onsite registration on the day of the meeting will be based on space availability. If you need special accommodations because of disability, please contact Pujita Vaidya (see FOR FURTHER INFORMATION CONTACT) at least 7 days before the meeting. Patients who are interested in presenting comments as part of the initial panel discussions will be asked to indicate in their registration which topic(s) they wish to address. They will also be asked to send via email to PatientFocused@fda.hhs.gov a brief summary of responses to the topic(s) questions. Panelists will be notified of their selection soon after the close of registration on June 5. FDA will try to accommodate all patients and patient advocate participants who wish to speak, either through the panel discussion or audience participation; however the duration of comments may be limited by time constraints. More information will be posted on the meeting Web site at least 5 days before the meeting date. Interested members of the public, including those who attend the meeting in person or through the Web cast, are invited to provide electronic or written responses to any or all of the questions pertaining to Topics 1 and 2 to the Division of Dockets Management (see ADDRESSES). Comments may be submitted until July 14, 2013. Dated: May 15, 2013. Leslie Kux, Assistant Commissioner for Policy. [FR Doc. 2013–12093 Filed 5–20–13; 8:45 am] BILLING CODE 4160–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2013–N–0001] Request for Nominations for Voting Members on Public Advisory Panels or Committees AGENCY: Food and Drug Administration, TKELLEY on DSK3SPTVN1PROD with NOTICES HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is requesting nominations for voting members on the Food Advisory Committee with expertise in microbiology, nutrition, food science, food technology, pediatric development, or nanotechnology in VerDate Mar<15>2010 17:07 May 20, 2013 Jkt 229001 food. Nominations will be accepted for current vacancies and those that will or may occur through June 30, 2013. FDA seeks to include the views of women and men, members of all racial and ethnic groups, and individuals with and without disabilities on its advisory committees, and therefore encourages nominations of appropriately qualified candidates from these groups. DATES: Nominations received on or before July 22, 2013 will be given first consideration for membership on the Food Advisory Committee. Nominations received after July 22, 2013 will be considered for nomination to the committee if nominees are still needed. ADDRESSES: All nominations for membership should be sent electronically to cv@oc.fda.gov, or by mail to Advisory Committee Oversight & Management Staff, 10903 New Hampshire Avenue, Bldg. 32, Rm. 5103, Silver Spring, MD 20993–0002. Information about becoming a member on a FDA advisory committee can also be obtained by visiting FDA’s Web site by using the following link https:// www.fda.gov/AdvisoryCommittees/ default.htm. FOR FURTHER INFORMATION CONTACT: Karen Strambler, Center of Food Safety and Applied Nutrition, Food and Drug Administration, 5100 Paint Branch Ave., Room 1C–016, College Park, MD 20740, 240–402–1913, FAX: 301–436– 2657, email: FoodAdvisoryCommittee@fda.hhs.gov. SUPPLEMENTARY INFORMATION: FDA is requesting nomination for voting members on the Food Advisory Committee. I. General Description of the Committee Duties The Committee provides advice to the Commissioner of Food and Drugs and other appropriate officials, on emerging food safety, food science, nutrition, and other food-related health issues that the FDA considers of primary importance for its food and cosmetics programs. The Committee may be charged with reviewing and evaluating available data and making recommendations on matters such as those relating to: (1) Broad scientific and technical food- or cosmetic-related issues; (2) the safety of new foods and food ingredients; (3) labeling of foods and cosmetics; (4) nutrient needs and nutritional adequacy; and (5) safe exposure limits for food contaminants. The Committee may also be asked to provide advice and make recommendations on ways of communicating to the public the potential risks associated with these PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 29757 issues and on approaches that might be considered for addressing the issues. II. Criteria for Voting Members Members and the Chair are selected by the Commissioner or designee from among individuals knowledgeable in the fields of physical sciences, biological and life sciences, food science, risk assessment, nutrition, food technology, molecular biology, and other relevant scientific and technical disciplines. Members will be invited to serve for terms of up to 4 years. The Committee consists of 17 standing members; of that 15 are voting members, which 2 are technically qualified members identified with consumer interest. In addition to the voting members the Committee has two nonvoting members who are identified with industry interests. III. Nomination Procedures Any interested person may nominate one or more qualified individuals for membership on the advisory committee. Self-nominations are also accepted. Nominations must include a current, complete resume or curriculum vitae for each nominee, including current business address and/or home address, telephone number, and email address if available. Nominations must also specify the advisory committee for which the nominee recommended. Nominations must also acknowledge that the nominee is aware of the nomination unless self-nominated. FDA will ask potential candidates to provide detailed information concerning such matters related to financial holdings, employment, and research grants and/or contracts to permit evaluation of possible sources of conflicts of interest. This notice is issued under the Federal Advisory Committee Act (5 U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees. Dated: May 15, 2013. Jill Hartzler Warner, Acting Associate Commissioner for Special Medical Programs. [FR Doc. 2013–12071 Filed 5–20–13; 8:45 am] BILLING CODE 4160–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as E:\FR\FM\21MYN1.SGM 21MYN1 29758 Federal Register / Vol. 78, No. 98 / Tuesday, May 21, 2013 / Notices TKELLEY on DSK3SPTVN1PROD with NOTICES amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel Program Project Supplement: Electron Detector. Date: June 6, 2013. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Warwick Seattle Hotel, 401 Lenora Street, Seattle, WA 98121. Contact Person: Wallace Ip, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5128, MSC 7840, Bethesda, MD 20892, 301–435– 1191, ipws@mail.nih.gov. Name of Committee: Infectious Diseases and Microbiology Integrated Review Group; Bacterial Pathogenesis Study Section. Date: June 11, 2013. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Garden Inn Washington DC/ Bethesda, 7301 Waverly Street, Bethesda, MD 20814. Contact Person: Richard G. Kostriken, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3192, MSC 7808, Bethesda, MD 20892, 301–402– 4454, kostrikr@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Bacterial Pathogens. Date: June 11, 2013. Time: 1:00 p.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Garden Inn Washington DC/ Bethesda, 7301 Waverly Street, Bethesda, MD 20814. Contact Person: Alexander D. Politis, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3210, MSC 7808, Bethesda, MD 20892, (301) 435– 1150, politisa@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR–13– 009: Secondary Dataset Analyses in Heart, Lung, and Blood Diseasesand Sleep Disorders. Date: June 17, 2013 Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications Place: Courtyard by Marriott, 5520 Wisconsin Avenue, Chevy Chase, MD 20815. VerDate Mar<15>2010 17:07 May 20, 2013 Jkt 229001 Contact Person: Julia Krushkal, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3148, MSC 7770, Bethesda, MD 20892, 301–435– 1782, krushkalj@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR–13– 009: Secondary Dataset Analyses in Heart, Lung, and Blood Diseases and Sleep Disorders: Conflicts. Date: June 17, 2013 Time: 8:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications Place: Courtyard by Marriott, 5520 Wisconsin Avenue, Chevy Chase, MD 20815. Contact Person: George Vogler, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3140, MSC 7770, Bethesda, MD 20892, (301) 237– 2693, voglergp@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Bioinformatics in Surgical Sciences, Imaging, and Independent Living. Date: June 17, 2013. Time: 9:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. Contact Person: Guo Feng Xu, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5122, MSC 7854, Bethesda, MD 20892, 301–237– 9870, xuguofen@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: May 15, 2013. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–12016 Filed 5–20–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of meeting of the National Cancer Advisory Board and NCI Board of Scientific Advisors. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. A portion of the National Cancer Advisory Board meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4), and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Advisory Board; Ad hoc Subcommittee on Global Cancer Research. Open: June 23, 2013, 5:00 p.m. to 6:30 p.m. Agenda: Discussion on Global Cancer Research. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, Bethesda, Maryland 20814. Contact Person: Dr. Edward Trimble, Executive Secretary, NCAB Ad hoc Subcommittee on Global Cancer Research, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Room 3W–562, Bethesda, MD 20892, (240) 276– 5796, trimblet@mail.nih.gov. Name of Committee: National Cancer Advisory Board, Ad hoc Subcommittee on Communications. Open: June 23, 2013, 6:40 p.m. to 8:10 p.m. Agenda: Discussion on Communications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, Bethesda, Maryland 20814. Contact Person: Dr. Lenora Johnson, Executive Secretary, NCAB Ad hoc Subcommittee on Communications National Cancer Institute, National Institutes of Health, 9606 Medical Center Drive, Room 2E–454, Bethesda, MD 20892, (240) 276– 6680, johnslen@mail.nih.gov. Name of Committee: National Cancer Advisory Board and NCI Board of Scientific Advisors. Open: June 24, 2013, 9:00 a.m. to 3:30 p.m. Agenda: Joint meeting of the National Cancer Advisory Board, and NCI Board of Scientific Advisors; NCI Board of Scientific Advisors Concepts Review and NCI Director’s reports and NCAB presentations. Place: National Institutes of Health, 9000 Rockville Pike, Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892. Contact Person: Dr. Paulette S. Gray, Executive Secretary, National Cancer Institute, National Institutes of Health, 9606 Medical Center Drive, Room 7W–444, Bethesda, MD 20892, (240) 276–6340. Name of Committee: National Cancer Advisory Board. Closed: June 24, 2013, 3:30 p.m. to 5:00 p.m. Agenda: Review of NCAB Grant Applications. E:\FR\FM\21MYN1.SGM 21MYN1

Agencies

[Federal Register Volume 78, Number 98 (Tuesday, May 21, 2013)]
[Notices]
[Pages 29757-29758]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-12016]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as

[[Page 29758]]

amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel Program Project Supplement: Electron Detector.
    Date: June 6, 2013.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Warwick Seattle Hotel, 401 Lenora Street, Seattle, WA 
98121.
    Contact Person: Wallace Ip, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5128, MSC 7840, Bethesda, MD 20892, 301-435-
1191, ipws@mail.nih.gov.

    Name of Committee: Infectious Diseases and Microbiology 
Integrated Review Group; Bacterial Pathogenesis Study Section.
    Date: June 11, 2013.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Garden Inn Washington DC/Bethesda, 7301 Waverly 
Street, Bethesda, MD 20814.
    Contact Person: Richard G. Kostriken, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3192, MSC 7808, Bethesda, MD 
20892, 301-402-4454, kostrikr@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Bacterial Pathogens.
    Date: June 11, 2013.
    Time: 1:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Garden Inn Washington DC/Bethesda, 7301 Waverly 
Street, Bethesda, MD 20814.
    Contact Person: Alexander D. Politis, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3210, MSC 7808, Bethesda, MD 
20892, (301) 435-1150, politisa@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR-13-009: Secondary Dataset Analyses in Heart, Lung, and 
Blood Diseasesand Sleep Disorders.
    Date: June 17, 2013
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications
    Place: Courtyard by Marriott, 5520 Wisconsin Avenue, Chevy 
Chase, MD 20815.
    Contact Person: Julia Krushkal, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3148, MSC 7770, Bethesda, MD 
20892, 301-435-1782, krushkalj@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR-13-009: Secondary Dataset Analyses in Heart, Lung, and 
Blood Diseases and Sleep Disorders: Conflicts.
    Date: June 17, 2013
    Time: 8:30 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications
    Place: Courtyard by Marriott, 5520 Wisconsin Avenue, Chevy 
Chase, MD 20815.
    Contact Person: George Vogler, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3140, MSC 7770, Bethesda, MD 20892, (301) 237-
2693, voglergp@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Bioinformatics in Surgical Sciences, Imaging, and Independent 
Living.
    Date: June 17, 2013.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892.
    Contact Person: Guo Feng Xu, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5122, MSC 7854, Bethesda, MD 20892, 301-237-
9870, xuguofen@csr.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: May 15, 2013.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-12016 Filed 5-20-13; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.